171 related articles for article (PubMed ID: 7870099)
1. Intralaboratory optimization and standardization of mutant screening conditions used for a lambda/lacI transgenic mouse mutagenesis assay (I).
Rogers BJ; Provost GS; Young RR; Putman DL; Short JM
Mutat Res; 1995 Mar; 327(1-2):57-66. PubMed ID: 7870099
[TBL] [Abstract][Full Text] [Related]
2. Interlaboratory comparison: liver spontaneous mutant frequency from lambda/lacI transgenic mice (Big Blue) (II).
Young RR; Rogers BJ; Provost GS; Short JM; Putman DL
Mutat Res; 1995 Mar; 327(1-2):67-73. PubMed ID: 7870100
[TBL] [Abstract][Full Text] [Related]
3. Inhalation of benzene leads to an increase in the mutant frequencies of a lacI transgene in lung and spleen tissues of mice.
Mullin AH; Rando R; Esmundo F; Mullin DA
Mutat Res; 1995 Mar; 327(1-2):121-9. PubMed ID: 7870081
[TBL] [Abstract][Full Text] [Related]
4. Transgenic lambda/lacI mutagenicity assay: statistical determination of sample size.
Callahan JD; Short JM
Mutat Res; 1995 Mar; 327(1-2):201-8. PubMed ID: 7870088
[TBL] [Abstract][Full Text] [Related]
5. The genetic analysis of lacI mutations in sectored plaques from Big Blue transgenic mice.
Stuart GR; Gorelick NJ; Andrews JL; de Boer JG; Glickman BW
Environ Mol Mutagen; 1996; 28(4):385-92. PubMed ID: 8991067
[TBL] [Abstract][Full Text] [Related]
6. Differential in vivo mutagenicity of the carcinogen/non-carcinogen pair 2,4- and 2,6-diaminotoluene.
Hayward JJ; Shane BS; Tindall KR; Cunningham ML
Carcinogenesis; 1995 Oct; 16(10):2429-33. PubMed ID: 7586147
[TBL] [Abstract][Full Text] [Related]
7. Comparison of mutant frequencies at the transgenic lambda LacI and cII/cI loci in control and ENU-treated Big Blue mice.
Zimmer DM; Harbach PR; Mattes WB; Aaron CS
Environ Mol Mutagen; 1999; 33(3):249-56. PubMed ID: 10334627
[TBL] [Abstract][Full Text] [Related]
8. A selectable system for mutation detection in the Big Blue lacI transgenic mouse system: what happens to the mutational spectra over time.
Knöll A; Jacobson DP; Nishino H; Kretz PL; Short JM; Sommer SS
Mutat Res; 1996 Jun; 352(1-2):9-22. PubMed ID: 8676922
[TBL] [Abstract][Full Text] [Related]
9. Spectra of spontaneous and mutagen-induced mutations in the lacI gene in transgenic mice.
Kohler SW; Provost GS; Fieck A; Kretz PL; Bullock WO; Sorge JA; Putman DL; Short JM
Proc Natl Acad Sci U S A; 1991 Sep; 88(18):7958-62. PubMed ID: 1832771
[TBL] [Abstract][Full Text] [Related]
10. A more efficient Big Blue protocol improves transgene rescue and accuracy in a adduct and mutation measurement.
Bielas JH
Mutat Res; 2002 Jul; 518(2):107-12. PubMed ID: 12113761
[TBL] [Abstract][Full Text] [Related]
11. Mutant frequency of lacI in transgenic mice following benzo[a]pyrene treatment and partial hepatectomy.
Shane BS; Lockhart AM; Winston GW; Tindall KR
Mutat Res; 1997 Jun; 377(1):1-11. PubMed ID: 9219573
[TBL] [Abstract][Full Text] [Related]
12. Aflatoxin B1 induced lacI mutation in liver and kidney of transgenic mice C57BL/6N: effect of phorone.
Autrup H; Jørgensen EC; Jensen O
Mutagenesis; 1996 Jan; 11(1):69-73. PubMed ID: 8671718
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous and ENU-induced mutation spectra at the cII locus in Big Blue Rat2 embryonic fibroblasts.
Watson DE; Cunningham ML; Tindall KR
Mutagenesis; 1998 Sep; 13(5):487-97. PubMed ID: 9800194
[TBL] [Abstract][Full Text] [Related]
14. Species-specific differences in hepatic mutant frequency and mutational spectrum among lambda/lacI transgenic rats and mice following exposure to aflatoxin B1.
Dycaico MJ; Stuart GR; Tobal GM; de Boer JG; Glickman BW; Provost GS
Carcinogenesis; 1996 Nov; 17(11):2347-56. PubMed ID: 8968048
[TBL] [Abstract][Full Text] [Related]
15. Mutagenic response of the endogenous hprt gene and lacI transgene in benzo[a]pyrene-treated Big Blue B6C3F1 mice.
Skopek TR; Kort KL; Marino DR; Mittal LV; Umbenhauer DR; Laws GM; Adams SP
Environ Mol Mutagen; 1996; 28(4):376-84. PubMed ID: 8991066
[TBL] [Abstract][Full Text] [Related]
16. Reporter gene transgenic mice as a tool for analyzing the molecular mechanisms underlying experimental carcinogenesis.
Nishikawa A; Suzuki T; Masumura K; Furukawa F; Miyauchi M; Nakamura H; Son HY; Nohmi T; Hayashi M; Hirose M
J Exp Clin Cancer Res; 2001 Mar; 20(1):111-5. PubMed ID: 11370817
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of in vivo mutation assays: analysis of hprt, lacI, cII/cI and as mutational targets for N-nitroso-N-methylurea and benzo[a]pyrene in Big Blue mice.
Monroe JJ; Kort KL; Miller JE; Marino DR; Skopek TR
Mutat Res; 1998 Oct; 421(1):121-36. PubMed ID: 9748534
[TBL] [Abstract][Full Text] [Related]
18. Induction of mutations by 2-acetylaminofluorene in lacI transgenic B6C3F1 mouse liver.
Ross JA; Leavitt SA
Mutagenesis; 1998 Mar; 13(2):173-9. PubMed ID: 9568591
[TBL] [Abstract][Full Text] [Related]
19. Tamoxifen induces G:C-->T:A mutations in the cII gene in the liver of lambda/lacI transgenic rats but not at 5'-CpG-3' dinucleotide sequences as found in the lacI transgene.
Davies R; Gant TW; Smith LL; Styles JA
Carcinogenesis; 1999 Jul; 20(7):1351-6. PubMed ID: 10383911
[TBL] [Abstract][Full Text] [Related]
20. The use of transgenic mice for short-term, in vivo mutagenicity testing.
Kohler SW; Provost GS; Kretz PL; Fieck A; Sorge JA; Short JM
Genet Anal Tech Appl; 1990 Dec; 7(8):212-8. PubMed ID: 2151115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
